[toc] 2020 April 2020. D’Genes y otras organizaciones elaboran un decálogo de necesidades de personas sin diagnóstico. 20 minutos March 20 2020. Global Rare Disease Group’s Focus: 1,000 New Therapies by 2027, Despite COVID-19. ALS News March 10 2020. Malattie rare: «e ora non dimentichiamo la ricerca di base». Vita February 28 2020. Q&A: ‘We […]
State of Play
The IRDiRC‘s State of Play report aims to inform stakeholders at large of developments in the field of rare diseases research in order to support decisions of policy makers and research funders. At the same time, the report is focused on informing the rare diseases community at large of the achievements and of observed trends, […]
Calls of IRDiRC Member Organizations
[toc] IRDiRC does not currently provide research grants. Its funding members contribute through their own rare disease research efforts and release a number of funding opportunities focused on rare disease research that adhere to IRDiRC Policies and Guidelines. In addition, some members collaborate to release joint funding calls and support joint research projects. These funding […]
IRDiRC Publications & Recommendations
Scientific Publications 2024 Advancing diagnosis and research for rare genetic diseases in Indigenous peoples. Gareth Baynam, Daria Julkowska, Sarah Bowdin, et al. Nature Genetics, 2024. Access the paper here. Drug repurposing for rare: progress and opportunities for the rare disease community. Anneliene Hechtelt Jonker, Daniel O’Connor, Anna Maria Gerdina Pasmooij, et al. Frontiers in […]
Task Forces & Working Groups
Introduction The IRDiRC Task Forces are created to tackle specific topics within rare diseases research proposed by the Constituent and/or Scientific Committees and selected as prioritized actions by the Consortium Assembly and the Operating Committee.Each Task Force reviews current barriers to efficient and effective rare disease research, and proposes solutions through policy recommendations and/or technical […]